HK Opening Bell | Hong Kong Stocks Open Lower, Hang Seng Index Down 0.45%, Most Large-Cap Tech Stocks Open Lower, CGN Mining Up Over 5%

HK Opening Bell09:23

Market Overview

The Hang Seng Index (HSI) opened on the back foot, easing 0.45% to 24,172.29 as investors took a cautious stance after recent strength. The China Enterprises Index (HSCEI) slipped 0.42% to 8,095.08, while the Hang Seng Tech Index (HSTECH) dipped 0.33% to 4,209.14, still clinging to the 4,200 level. The broader Hang Seng China (HSCCI) managed a modest 0.27% uptick to 4,009.24, but overall market breadth leaned negative in early trade.

Risk sentiment was clouded by sharp profit‐taking in biotech counters, which dominated the morning’s laggards. Conversely, select industrial and consumer hardware names eked out gains, offering a defensive pocket as traders weighed external growth concerns and the recent rally’s sustainability.

Sector Performance

Large Technology Names

Alibaba falls 1.39%, JD Health falls 1.02%, Meituan falls 0.99%, Baidu falls 0.93%, Tencent falls 0.61%, Kuaishou falls 0.27%, Xiaomi falls 0.25%, JD.com falls 0.19%, Lenovo rises 0.73%, NetEase rises 0.32%

HK Top Gainers 10

Stock

Code

Price (HK$)

Gain

CGN MINING

01164

2.21

5.23%

HAIZHI TECH GP

02706

40.80

4.35%

EB SECURITIES

06178

7.18

4.28%

DEEPZERO

02723

735.00

4.03%

JIANGSU EXPRESS

00177

10.80

3.15%

JIA YAO HLDGS

01626

23.30

3.01%

WEICHAI POWER

02338

30.36

2.99%

TCL ELECTRONICS

01070

18.20

2.82%

XIAOCAIYUAN

00999

9.25

2.49%

OMNIVISION

00501

73.20

2.31%

Filter: Market cap above HK$10 billion

4. HK Top Losers 10

Stock

Code

Price (HK$)

Loss

GENSCRIPT BIO

01548

44.00

-10.46%

INSILICO

03696

56.60

-4.55%

JOINN

06127

30.80

-4.35%

CSOP SK Hynix Daily Max (2x) Leveraged Product

07709

38.30

-4.11%

ZAI LAB

09688

20.00

-3.85%

CHERY AUTO

09973

25.50

-3.19%

WUXI BIO

02269

56.10

-3.11%

BAIGE DIGITAL

02672

63.00

-2.78%

XTALPI

02228

8.10

-2.47%

BEONE MEDICINES

06160

215.20

-2.45%

Filter: Market cap above HK$10 billion

5. Opening Summary

The Hong Kong market opened on a softer note as the Hang Seng Index slipped 0.45%, mirroring mild profit-taking across heavyweight constituents. Despite a brief attempt to stabilise, selling pressure in pharmaceuticals and biotechnology capped any rebound, while the HSCEI also tracked lower by 0.42%. The Hang Seng Tech Index edged below water, suggesting caution toward growth names after recent advances.

Large-cap internet stocks were mixed but tilted negative. Alibaba, JD Health and Meituan led declines of up to 1.4%, while Lenovo and NetEase bucked the trend with modest gains, hinting at selective buying in hardware and gaming-related counters. Tencent eased 0.6%, keeping the broader tech gauge under check.

Individual volatility centred on biotech: Genscript Bio tumbled over 10% to top the loser board, joined by Insilico and Zai Lab, dragging the sector lower. On the upside, uranium play CGN Mining surged more than 5%, while industrial names such as Weichai Power and TCL Electronics advanced, reflecting rotation into traditional cyclicals.

With sector indices showing muted early readings, traders will watch for follow-through in industrial momentum and any stabilisation in healthcare to gauge market breadth. No major IPOs debuted this morning, keeping focus squarely on earnings updates and policy signals for further direction.

Source: Public market data and media reports

Disclaimer: For reference only. Not investment advice.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment